ginkgolide b has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Domańska-Janik, K; Zabøocka, B | 1 |
1 other study(ies) available for ginkgolide b and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
Article | Year |
---|---|
PAF antagonist, BN52021, inhibits [3H]D-aspartate release after ischaemia in vitro.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Aspartic Acid; Brain Ischemia; Diterpenes; Enzyme Activation; Ginkgolides; Hippocampus; In Vitro Techniques; Isoquinolines; Lactones; Phorbol 12,13-Dibutyrate; Piperazines; Platelet Activating Factor; Potassium; Protein Kinase C; Rats; Rats, Wistar; Tritium | 1994 |